Prostate Cancer Clinical Trial

Outcome Assessment of an Active Surveillance Program for Low Risk Prostate Cancer: An Observational Study

Summary

The purpose of this research study is to monitor the feasibility and outcome of the Active Surveillance Program for men with low risk prostate cancer.

View Full Description

Full Description

The purpose of this observational study is to prospectively monitor the outcome associated with men who meet the eligibility criteria for low risk prostate cancer and elected to participate in the active surveillance program at The Center for Cancer Prevention and Treatment at St. Joseph Hospital. We hope to demonstrate that men who are compliant with a closely monitored active surveillance program for low risk prostate cancer will achieve favorable outcomes by: 1) avoiding the side effects of definitive therapy that may not be necessary; 2) retaining quality of life (QOL) and normal activities; 3) avoiding unnecessary treatment; and 4) decreased health care costs. In addition, we will monitor the possible adverse outcomes that may be associated with the active surveillance program including suboptimal response and/or greater side effects due to delayed initiation of therapy; psychological impact on the patients and caregivers due to anxiety of living with an untreated cancer and/or the requirement for frequent medical examination and periodic prostate biopsies.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

At least 18 years of age
Histological documented adenocarcinoma of the prostate either newly diagnosed or previously diagnosed. Subjects who are diagnosed more than 3 months prior to time of enrollment in the active surveillance program must have biopsy repeated.
PSA < 10 ng/ml within 1 month of program enrollment
Clinical stage less than or equal to T2a
Biopsy sampling with at least 10-12 cores
Gleason score less than or equal to 3 + 3
No more than 2 cores involved
No core more than 50% involved
Eligible for definitive therapy
Able to provide informed consent
Able to complete a QOL questionnaire
Able to comply with the scheduled follow-up appointments

Exclusion Criteria:

See inclusion criteria for eligibility

Study is for people with:

Prostate Cancer

Estimated Enrollment:

8

Study ID:

NCT01376661

Recruitment Status:

Terminated

Sponsor:

St. Joseph Hospital of Orange

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

St. Joseph Hospital of Orange
Orange California, 92868, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

8

Study ID:

NCT01376661

Recruitment Status:

Terminated

Sponsor:


St. Joseph Hospital of Orange

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider